MUMBAI: Sun PharmaBSE 0.24 % has announced a distribution alliance in Japan with Mitsubishi Tanabe for a phased transfer of manufacturing and marketing rights of 14 products that it acquired fromNovartisBSE 0.49 %...
Alzheimer’s, Parkinson’s Drugs May Be M&A Targets, Huang Says
Treatments for neurodegenerative diseases could emerge as the next hot spot in health-care mergers and acquisitions, Morgan Stanley’s head of M&A for the Americas said. “Several years out, demographics would point...
KaloBios Pharmaceuticals announces Martin Shkreli’S sale of his stake in the company
KaloBios Pharmaceuticals Inc * KaloBios announces Martin Shkreli’S sale of his stake in the company * Shkreli continues to be restricted from certain further actions concerning company for a period of time *...
Guanhao Biotech completes acquisition of Zhuhai-based pharmaceutical company
Guanhao Biotech Co Ltd : * Says it completes acquisition of Zhuhai-based pharmaceutical company * Previous plan was disclosed on March 15 Source text in Chinese: goo.gl/KqaWod Further company coverage: (Beijing Headline...
Nichi-Iko Pharmaceutical fully buys Sagent Pharmaceuticals, Inc. via takeover bid
Nichi-Iko Pharmaceutical Co Ltd : * Says it completed full acquisition of Sagent Pharmaceuticals, Inc. via takeover bid, effective Aug. 29(the U.S. time) Source text in Japanese:goo.gl/42E3Yf Further company coverage:...
Neuland Labs gets board nod to merge 2 group cos with self
Drug firm Neuland Laboratories today said its board has approved the merger of Neuland Health Sciences and Neuland Pharma Research with the company. “The Board of Directors of the company…Have in-principle...
Aurobindo, Intas in race for $1 billion buyout of Teva UK, submit binding offers
MUMBAI: Homegrown drug makers AurobindoBSE -0.44 % and Intas are among the final contenders for the UK and Irish portfolio of Israeli generics behemoth Teva, put up for sale to comply with European anti-trust...
Taparias pick up majority stake in guardian lifecare
MUMBAI: The TapariaBSE 4.99 % family, which had sold Famycare, the female healthcare business to drug maker Mylan for Rs 4,600 crore last year, has picked a majority stake in Guardian Lifecare, India’s third...
Pfizer to buy antibiotics business from AstraZeneca for $725 mn
Hong Kong/London: Pfizer Inc. agreed to buy an antibiotics business from AstraZeneca Plc for $725 million as well as other payouts, settling for one piece of a company it once tried to acquire. Pfizer will pay $550...
Pfizer Mega-Merger Not as Likely as Smaller Deals
Only for a company like Pfizer is a $14 billion acquisition considered “bolt-on” and “barely a needle-mover.” But shareholders of the $213 billion drugmakers may have to get used to describing...
With an aim of expansion, pharma companies like Lupin and Torrent eyeing overseas acquisition
MUMBAI: India’s top pharmaceutical companies are set to embark on an acquisition spree to bulk up their overseas presence. LupinBSE 0.60 %, Torrent, ZydusBSE -0.05 % Cadila, Intas, AurobindoBSE 1.34 %, Dr...
ChrysCapital in talks to exit Eris Lifesciences
Mumbai: Private equity (PE) firm ChrysCapital is looking to exit its investment in pharmaceutical firm Eris Lifesciences through an initial public offering (IPO) and has initiated talks for the same, said three people...
